Sitagliptin Phenylcrotonyl Analog
Impurity
This molecule is a impurity of Sitagliptin.

Impurity
Sitagliptin Phenylcrotonyl Analog
Cat. No. ANT-SGT-09CAS 1253056-18-6Please Enquire
Technical Data
Cat. No.ANT-SGT-09
CAS1253056-18-6
Mol. FormulaC16H12F6N4O
Mol. Weight390.29 g/mol
IUPAC(E)-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)but-2-en-1-one
SMILESC1CN2C(=NN=C2C(F)(F)F)CN1C(=O)/C=C/CC3=CC(=C(C=C3F)F)F
InChIInChI=1S/C16H12F6N4O/c17-10-7-12(19)11(18)6-9(10)2-1-3-14(27)25-4-5-26-13(8-25)23-24-15(26)16(20,21)22/h1,3,6-7H,2,4-5,8H2/b3-1+
InChI KeyQSSHJJFVCWMIKH-HNQUOIGGSA-N
PurityNA
For research and analytical use only — not for human or veterinary consumption.
Description
Overview
Sitagliptin Phenylcrotonyl Analog, Sitagliptin, 1253056-18-6, (E)-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)but-2-en-1-one
Anant Labs is the renowned and Authentic Manufacturer and Supplier of Sitagliptin Phenylcrotonyl Analog in India.
At Anant, we have expertise in synthetic organic chemistry and pharmaceutical analysis and we provide cost effective and accurate custom research services to the industry.
Synonyms
(E)-1-(3-(Trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-2-en-1-one(2E)-1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-2-buten-1-oneSitagliptin Tablets EP Impurity FP-D1253056-18-6BA5DQ297BM(2E)-1-(5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo(4,3-a)pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)-2-buten-1-one(E)-1-(3-(Trifluoromethyl)-5,6-dihydro-(1,2,4) triazolo(4,3-a)pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-2-en-1-one2-Buten-1-one, 1-(5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo(4,3-a)pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)-, (2E)-RefChem:196431Sitagliptin Deamino Impurity 1
Quick Actions
Product Summary
NameSitagliptin Phenylcrotonyl Analog
Cat. No.ANT-SGT-09
CAS1253056-18-6
Inv. StatusPlease Enquire









